Please ensure Javascript is enabled for purposes of website accessibility

Argenta Technologies

Drug delivery technologies engineered for animal health

Differentiate your product with a proven, licensable platform

Get to market faster with a validated, patent-protected drug delivery technology developed exclusively for veterinary use. License one of our three platforms for your molecule, with development, manufacturing, and regulatory support from the same team.

Talk to our formulation scientists
Veterinarian giving a golden retriever puppy an injection, showing injectable veterinary drug delivery technology

Up to 34% drug loading in our microspheres

343 days of controlled release from a single capsule

>85% full acceptability for our soft chews

Our Technologies

Choose the platform that fits your molecule and your species

Icon of lipid microspheres for long-acting injectable drug delivery in animals

Microspheres

Reduce dosing frequency with biodegradable lipid microspheres that release your API over one week to 12 months. They’re small enough for standard syringe injection, and they mask bitter flavours in oral formulations.

Icon of a timer for controlled-release intraruminal capsules

Controlled-release capsules

Treat cattle and sheep for up to a year from a single administration, with zero-order release proven over 343 days and multiple APIs delivered from one device.

Icon of a pet medicine bottle for palatable soft chews

Soft chews

Give pets a dose they’ll take, with >85% full acceptability. Continuous low-temperature extrusion with no added water delivers tablet-level stability in a treat-like format for pharmaceutical and nutraceutical products.

Talk to our formulation scientists

Get more from your molecule with a licensed platform

Bring new products to market faster

Integrate your molecule with a platform that’s already validated, so you avoid the time and cost of developing a new dosage form in-house.

Cattle at a feed fence, representing livestock products built on a licensed drug delivery technology
Veterinarian offering a dog medication from a dropper bottle, showing easier administration for pets

Make treatment easier to give

Fewer doses, better palatability, and simpler administration make treatment more reliable for pets, livestock, and the people caring for them.

Extend the life of an existing product

Reformulate an existing molecule on a patent-protected platform to differentiate it and protect its place in the market.

Formulation scientist pipetting samples in a lab to reformulate an animal health product

Move from license to commercial supply with one team

When you license a platform, the same organisation takes your product from feasibility to commercial manufacture.

Early phase development

Check compatibility, release profile options, and formulation strategy before you make a significant investment.

Formulation development

Optimise the platform for your API, target species, and therapeutic goals.

Process development

Scale and validate your process from pilot to commercial GMP batches.

Regulatory affairs

Compile your dossier with our in-house animal health regulatory team.

Contract manufacturing

Manufacture at commercial scale in our GMP facilities.

Talk to our formulation scientists

Featured resources

Palatable soft chews for animal health products video thumbnail

Palatable soft chews for animal health products

Watch the video
Developing a palatable and effective soft chew for companion animal medicine eBook cover

Developing a palatable and effective soft chew for companion animal medicine

Download the eBook
Accelerating the path to market for microspheres eBook cover

Accelerating the path to market for microspheres

Download the eBook
Explore all resources

FAQs

Which veterinary drug delivery systems can I license from Argenta?

You can license three proprietary platforms developed exclusively for animal health: controlled-release microspheres, controlled-release intraruminal capsules, and palatable soft chews.

Which animal species are your drug delivery technologies for?

Our technologies support cats, dogs, horses, rabbits, cattle, swine, goats, and sheep. Soft chews are designed for companion animals, and intraruminal capsules for cattle and sheep.

Are these technologies patented?

Yes. Our soft chews are covered by two US patents for formulation and process, expiring in 2034. The intraruminal capsule hardware and formulation are protected by patents expiring between 2039 and 2043 in North America, Europe, Australia and New Zealand, and Asia. These protections also extend to partners who license the technologies.

Can your technologies work with my existing molecule?

Each platform has been formulated with a wide range of APIs. We run a feasibility study early to assess compatibility, release profile options, and formulation strategy, so you know whether a platform fits before you make a significant investment.

Can one device deliver multiple APIs?

Yes. Controlled-release intraruminal capsules use a multi-API pulse-release design. By alternating active and blank tablets within one device, they can deliver drug combinations, time-delayed doses, or washout periods from a single administration, which suits parasite control programmes and combination therapies.

How long can these technologies sustain API release?

Microspheres can be tuned to release from one week to 12 months, depending on the formulation. Controlled-release intraruminal capsules are designed for once-a-year dosing, with constant release proven over 343 days. Both are optimised during feasibility to match your therapeutic goals and target species.

What support do I get when I license a technology?

Our team supports you from feasibility through formulation development, GMP manufacturing, and regulatory submission, with the engagement structured around your development stage and timeline.

Healthy animals. Let’s make it happen, together.

Find the drug delivery technology that fits your molecule, species, and goals.
Talk to our formulation scientists